Please login to the form below

Not currently logged in
Email:
Password:

iPierian

This page shows the latest iPierian news and features for those working in and with pharma, biotech and healthcare.

AbbVie and C2N take tau antibody into clinic

AbbVie and C2N take tau antibody into clinic

Last year, Bristol-Myers Squibb bought into the field via a $725m deal to acquire iPierian.

Latest news

  • BMS buys Alzheimer's player iPierian in $725m deal BMS buys Alzheimer's player iPierian in $725m deal

    In addition to the tau-targeted pipeline, BMS will also tap into iPierian's expertise in disease models, which grew out of earlier work on stem cells. ... BMS has paid $175m upfront for iPierian, with the potential for additional development and

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
90TEN

90TEN is a global healthcare communications consultancy with a mission to make people healthier and happier through life-changing education and...

Latest intelligence

7 important considerations for creating an inclusive clinical trial website
You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...
Employee engagement
Route 66: can remote working put two-thirds of us back on the road to engaged employment?
Pre-pandemic, 66% of the world’s workforce weren’t engaged in their jobs – Chris Ross examines how the rush to remote working has impacted employee engagement...
Demonstrating the value of HCP self-serve portals
Develop the art of setting KPIs and metrics aligned to your specific objectives, target personas, key educational messages, content, website features and journeys....

Infographics